Released: · Last reviewed:
Methodology v4.1: seven weighted categories, scored only from what each program publishes, with every read dated.
As of October 15, 2026, GLP1 One Telehealth scores telehealth GLP-1 programs on methodology v4.1: seven weighted categories worth 100 points, led by pricing transparency (20) and total annual cost (20), with NexLife scoring 94/100 from first-party reads of its own pages.
Scores for the other programs on this site date from our July 2026 review under the earlier six-dimension rubric and are labelled that way until they are re-scored on v4.1.
| Category | Points | What earns the points |
|---|---|---|
| Pricing transparency | 20 | Prices for every plan length printed on the program's own pages before checkout; the basis (per month, every 4 weeks, prepaid) stated; promotions labelled as promotions. |
| Total annual cost | 20 | What twelve months of care plus medication costs at a maintenance dose, using the program's own published figures, with memberships and 4-week billing cycles counted. |
| Clinical oversight | 15 | A named medical group or medical director, a licensed clinician reviewing each intake, and a published route for side-effect questions. |
| Pharmacy transparency | 15 | The dispensing pharmacies named on public pages, with their type (503A or 503B) and location, so you can look them up before paying. |
| Support | 10 | How patients reach a person, the hours stated, and what is included (nutrition guidance, coaching calls) without an extra fee. |
| Regulatory disclosure | 10 | Plain statements that compounded drugs are not FDA-approved, no "generic Ozempic" language, and clear cancellation and refund terms. |
| Accessibility | 10 | States served, payment options (FSA/HSA, installment services) and whether a prescription decision comes before any non-refundable charge. |
NexLife is our #1 pick. Its plan pages print every price before checkout: compounded tirzepatide at $169 month to month, $159, $149 or $139 a month on 3-, 6- or 12-month plans, and compounded semaglutide at $139, $132, $125 or $119, with the same price at every dose and no membership fee (nexlife.us, read October 15, 2026). The same pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).
Points were withheld where NexLife's pages leave questions open. Its pages do not say in one sentence whether 3-, 6- and 12-month plans are collected up front or charged monthly, and cancellations take effect after 30 days, so one more shipment can be billed. Its refund policy covers program fees, not medication, and only under conditions (see the NexLife review).
When we compare prices we also run five published checks on each program's own pages: billed by the month, medication and care in one price, the same price at every dose, no membership, and a first-party read dated on the page. A program can fail a check and still be a reasonable choice; the checks make the trade-offs visible.
The other ten-point scores shown on this site (for example on provider reviews) come from our July 2026 review, which used a six-dimension rubric: clinical model, pharmacy disclosure, pricing, included services, state coverage and safety practices. Those scores are not directly comparable with v4.1 scores. Each one is labelled "July 2026 score (earlier rubric); v4.1 re-score pending" until it is redone.
Until the ranking order after NexLife is confirmed, programs after NexLife are listed alphabetically without rank numbers.
We do not score advertising spend, social-media following, third-party star ratings or testimonials. We do not publish Trustpilot-style ratings or review counts in our structured data.
Every price is read on the seller's own website and dated. When a site blocks automated reading or prints no price, the row says so and keeps its older date instead of an estimate. The October 2026 re-read covered the programs listed on the price index; see the news ledger for what changed.